Table 2.
KEGG pathways enrichment analysis results.
| Term | Gene count | % | P-value | Fold Enrichment | Bonferroni | Benjamini | FDR |
|---|---|---|---|---|---|---|---|
| hsa05200:Pathways in cancer | 21 | 14.09 | 0.0000 | 4.8365 | 0.0000 | 0.0000 | 0.0000 |
| hsa04151:PI3K-Akt signaling pathway | 11 | 7.38 | 0.0040 | 2.8859 | 0.4505 | 0.0950 | 4.6553 |
| hsa04014:Ras signaling pathway | 9 | 6.04 | 0.0030 | 3.6045 | 0.3664 | 0.0872 | 3.5673 |
| hsa04110:Cell cycle | 8 | 5.37 | 0.0004 | 5.8395 | 0.0547 | 0.0277 | 0.4470 |
| hsa04310:Wnt signaling pathway | 8 | 5.37 | 0.0007 | 5.2471 | 0.1017 | 0.0351 | 0.8506 |
| hsa04015:Rap1 signaling pathway | 8 | 5.37 | 0.0077 | 3.4481 | 0.6840 | 0.1517 | 8.7631 |
| hsa05166:HTLV-I infection | 8 | 5.37 | 0.0202 | 2.8508 | 0.9531 | 0.3178 | 21.6204 |
| hsa05206:MicroRNAs in cancer | 7 | 4.70 | 0.0908 | 2.2153 | 1.0000 | 0.6140 | 67.9138 |
| hsa05218:Melanoma | 6 | 4.03 | 0.0010 | 7.6489 | 0.1395 | 0.0369 | 1.1893 |
| hsa05205:Proteoglycans in cancer | 6 | 4.03 | 0.0665 | 2.7153 | 1.0000 | 0.5479 | 56.0270 |
| hsa04114:Oocyte meiosis | 5 | 3.36 | 0.0325 | 4.0771 | 0.9930 | 0.3911 | 32.6281 |
| hsa04390:Hippo signaling pathway | 5 | 3.36 | 0.0821 | 2.9971 | 1.0000 | 0.6006 | 64.0428 |
| hsa05217:Basal cell carcinoma | 4 | 2.68 | 0.0207 | 6.7046 | 0.9569 | 0.2949 | 22.1504 |
| hsa04115:p53 signaling pathway | 4 | 2.68 | 0.0363 | 5.4037 | 0.9961 | 0.3957 | 35.6682 |